Role of Vitamin D Supplementation with Liv-52 on Inflammatory Biomarkers in Carbon Tetrachloride (Ccl4) Induced Liver Disease in Wister Rats

Main Article Content

K. Ponnazhagan
G. Lakshmi
Sumanth Kumar B
Ursula Sampson
N. Muninathan

Abstract

Introduction: Liver disease is a significant global health concern, with a wide range of etiologies and adverse effects on overall health. Among the various causes of liver disease, exposure to hepatotoxins such as carbon tetrachloride (CCl4) has been widely studied. Inflammatory processes play a crucial role in the development and progression of liver disease. Inflammatory biomarkers, serve as important indicators of liver injury and can provide insights into the underlying inflammatory response. Therefore, identifying effective interventions that can modulate these inflammatory biomarkers holds great promise for the management of liver disease.  The goal of the current study was to examine the anti-inflammatory effects of vitamin D combined with Liv-52 on liver disease caused by CCl4. Materials and Methods: Male Wistar rats were given CCl4, twice a week for nine weeks, Liv-52 (1 mL/kg b.w), and vitamin D (500 IU/kg b.w) orally for nine weeks. The effects of vitamin D supplementation along with Liv-52 on inflammatory markers were estimated in the serum samples. Results:  When compared to control animals, it was discovered that the hepatotoxic carrying animals had higher serum concentrations of IL-6, TGF-β and TNF-α. Supplementation of vitamin D (group III) and Liv-52 (group IV) treated rats showed significantly reduced the levels of IL-6, TGF-β and TNF-α when compared with group II animals. The supplementation with combination of vitamin D and liv-52 more significantly reduced the levels of IL-6, TGF-β and TNF-α. The comparative analysis between group III vs IV, the protective function of vitamin D in-isolation is similar to the protection by Liv-52 in-isolation, there is no marker difference between the two and both have significant protection effect. Conclusion:  The results obtained indicate that the combination of vitamin D supplementation and Liv-52 exhibited beneficial effects on inflammatory biomarkers in CCl4-induced liver disease.

Downloads

Download data is not yet available.

Article Details

How to Cite
Ponnazhagan, K., Lakshmi, G. ., B, S. K., Sampson, U. ., & Muninathan, N. . (2022). Role of Vitamin D Supplementation with Liv-52 on Inflammatory Biomarkers in Carbon Tetrachloride (Ccl4) Induced Liver Disease in Wister Rats. Journal of Advanced Zoology, 43(1), 432–439. https://doi.org/10.53555/jaz.v43i1.1391
Section
Articles

References

Austin, J.2003. Day-of-Week Patterns in Toxic Air Contaminants in Southern California. J Air Waste

Manage Assoc, 53:889–896.

Amoore, J.E. & Hautala, E.1983. Odor as an ald to chemical safety: Odor thresholds compared with threshold

limit values and volatilities for 214 industrial chemicals in air and water dilution, J Appl Toxicol, 3:272–

Xu, J.Y. Su, Y.Y. Cheng, J.S. 2010. Protective effects of fullerenol on carbon tetrachloride-induced acute

hepatotoxicity and nephrotoxicity in rats, Carbon N Y, 48:1388–1396.

Fortea, J.I. Fernández-Mena, C. Puerto, M.2018. Comparison of Two Protocols of Carbon

TetrachlorideInduced Cirrhosis in Rats – Improving Yield and Reproducibility, Sci Rep, 8:9163.

Frezza, E.E. Gerunda, G.E. Farinati, F. 1994. CCL4-induced liver cirrhosis and hepatocellular carcinoma in

rats: relationship to plasma zinc, copper and estradiol levels, Hepatogastroenterology, 41:367–9.

Han, S. Li, T. Ellis, E. 2010. A Novel Bile Acid-Activated Vitamin D Receptor Signaling in Human

Hepatocytes, Mol Endocrinol, 24:1151–1164.

Malham, M. 2011. Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology. World

J Gastroenterol, 17:922.

McMahon, M. Itoh, K.Yamamoto, M. Hayes, J.D. 2003. Keap1-dependent Proteasomal Degradation of

Transcription Factor Nrf2 Contributes to the Negative Regulation of Antioxidant Response Elementdriven

Gene Expression, J Biol Chem, 278:21592–21600

Holmes, S. Abbassi, B. Su, C. 2013. Oxidative Stress Defines the Neuroprotective or Neurotoxic Properties

of Androgens in Immortalized Female Rat Dopaminergic Neuronal Cells, Endocrinology, 154:4281– 4292.- 439 - Available online at: https://jazindia.com

Razzaque, M.S. 2012. FGF23, Klotho and Vitamin D Interactions, Adv Exp Med Biol, 84–91.

Abramovitch, S. Dahan-Bachar, L. Sharvit, E. 2011. Vitamin D inhibits proliferation and profibrotic marker

expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats, Gut, 60:1728–

Ding, N. Yu, R.T. Subramaniam, N. 2013. A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic

Fibrotic Response, Cell, 153:601–613.

Saini, M.R. & Saini, N.1985. Liv. 52 protection against radiation induced lesions in mammalian liver.

Radiobiol Radiother, 26:379–84.

Malik, K. 1979. Role of Liv.52 in Hepatitis and Cirrhosis of the Liver, Curr Med Pract, 23:5

Dhumal, M.S. & Mane, P.S. 1989. Effect of Liv-52 on carbon tetrachloride, Indian J Pharmacol, 21:96–9.

Chan, & Perlstein, E. 1987. Immunoassay, A Practical Guide, Acad Press New York, 71

Connolly, M.K. Bedrosian, A.S. Mallen Clair, J. Mitchell, A.P. Ibrahim, J. Stroud, A. Pachter, H.L. BarSagi,

D. Frey, A.B. Miller, G. 2009. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNFalpha, J Clin Invest, 119: 3213-3225.

Li, Z.M. Sun, J.H. Yang, X.M. 2015. Recent advances in molecular magnetic resonance imaging of liver

fibrosis, Biomed, res, Int, 595467.

Luckey, S.W. & Petersen, D.R. 2001. Activation of Kupffer cells during the course of carbon

tetrachlorideinduced liver injury and fibrosis in rats, Exp Mol Pathol, 71:226-240.

White, P. & Cooke, N. 2000. The Multifunctional Properties and Characteristics of Vitamin D-binding

Protein. Trends Endocrinol Metab, 11:320–327.

Barchetta, I. Carotti, S. Labbadia, G. 2012. Liver vitamin D receptor, CYP2R1, and CYP27A1 expression:

relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or

hepatitis C virus, Hepatology, 56:2180–2187.

Zhang, Y. Leung, D.Y.M. Richers, B.N. 2012. Vitamin D Inhibits Monocyte/Macrophage Proinflammatory

Cytokine Production by Targeting MAPK Phosphatase-1, J Immunol, 188:2127– 2135.

Cheng, J.B. Motola, D.L. Mangelsdorf, D.J. Russell, D.W. 2003. De-orphanization of Cytochrome P450

R1, J Biol Chem, 278:38084–38093.

Salter, M.L. Lau, B. Mehta, S.H. 2013. Correlates of Elevated Interleukin-6 and C-Reactive Protein in

Persons With or at High Risk for HCV and HIV Infections, JAIDS J Acquir Immune Defic Syndr, 64:488–

Iruzubieta, P. 2014. Vitamin D deficiency in chronic liver disease, World J Hepatol, 6:901.

Kim, Y.C. Masutani, H. Yamaguchi, Y. 2001. Hemin-induced Activation of the Thioredoxin Gene by Nrf2, J

Biol Chem, 276:18399–18406.

Das, R.A. & Parangusa, B.V. 1982. Clinical trial of Liv.52 in burns Probe, XXI, 3:192–197

Most read articles by the same author(s)